8-K: Current report
8-K: Current report
SCHEDULE 13D/A: Others
SCHEDULE 13D/A: Others
SCHEDULE 13D/A: Others
4: Statement of changes in beneficial ownership of securities-Director LOBELL J JAY
3: Initial statement of beneficial ownership of securities-10% Owner Fortress Biotech, Inc.
3: Initial statement of beneficial ownership of securities-10% Owner Fortress Biotech, Inc.
4: Statement of changes in beneficial ownership of securities-Director Hoenlein Malcolm
4: Statement of changes in beneficial ownership of securities-Director Lorenz Kevin
4: Statement of changes in beneficial ownership of securities-Director Harvey Jimmie
4: Statement of changes in beneficial ownership of securities-Director Lu Lucy
4: Statement of changes in beneficial ownership of securities-Director Klein Dov
4: Statement of changes in beneficial ownership of securities-Officer WEISS MICHAEL S
4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.
4: Statement of changes in beneficial ownership of securities-Officer ROSENWALD LINDSAY A MD
4: Statement of changes in beneficial ownership of securities-Officer Jin David
8-K: Current report
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fortress Biotech, Inc.(8.9%)
10-Q: Q3 2024 Earnings Report